In this context of amyloidosis and tau phosphorylation, our results showed that several neurology biomarkers in pEVs samples were highly negatively correlated with CSF p-tau181 only in EOMCI Aβ( +) patients. This evidence concerns the gene MAPT and amyloidosis.